The work is based on the materials of official statistical reporting, the analysis of which was carried out for 10 years, divided into two five-year periods (2009-2013 and 2014-2018). Absolute and intensive rates of morbidity and distribution of bladder cancer of the adult population of Ukraine in the regional aspect, taking into account sex were studied, the basic indicators of the prevalence of pathology were analyzed as well. The revealed unfavorable situation is characterized by a steady increase in morbidity and prevalence at a slower pace during 2014-2018. It is noteworthy the high level of morbidity in men, which is growing against the background of its stabilization among women. At the same time, there was noted the tendency in the ...
Introduction: Bladder cancer is the ninth common cancer in the world, the third common cancer among ...
The study uses data from state and industry official statistics for 2008-2017. Absolute and relative...
Bladder cancer accounts for approximately 5-10% of all cancers in the United States and Europe and i...
The work is based on the materials of official statistical reporting, the analysis of which was carr...
Urinary bladder cancer is one of the most common cancers occurring in those aged older, especially b...
Objective: Bladder cancer is the twelfth leading cancer and the fifteenth leading cancer-causing dea...
Bladder cancer is a heterogeneous disease with a variable natural history. At one end of the spectru...
The paper reviews the basic avenues of research and the recent developments in clinical research. Bl...
The paper presents the results of a long (10-year) analysis of mortality rates of different segment...
Background: Bladder cancer (BC) is the most common malignancy of the urinary tract caused by the unc...
Bladder cancer is a heterogeneous disease with a variable natural history. At one end of the spectru...
The study objective is to analyze incidence of cancer morbidity and morality in Russia and some form...
Introduction The current study determined the level and trends associated with the incidence, death ...
The work is devoted to the dynamics of morbidity and prevalence of chronic cystitis among the male p...
The study uses data from state and industry official statistics for 2008-2017. Absolute and relative...
Introduction: Bladder cancer is the ninth common cancer in the world, the third common cancer among ...
The study uses data from state and industry official statistics for 2008-2017. Absolute and relative...
Bladder cancer accounts for approximately 5-10% of all cancers in the United States and Europe and i...
The work is based on the materials of official statistical reporting, the analysis of which was carr...
Urinary bladder cancer is one of the most common cancers occurring in those aged older, especially b...
Objective: Bladder cancer is the twelfth leading cancer and the fifteenth leading cancer-causing dea...
Bladder cancer is a heterogeneous disease with a variable natural history. At one end of the spectru...
The paper reviews the basic avenues of research and the recent developments in clinical research. Bl...
The paper presents the results of a long (10-year) analysis of mortality rates of different segment...
Background: Bladder cancer (BC) is the most common malignancy of the urinary tract caused by the unc...
Bladder cancer is a heterogeneous disease with a variable natural history. At one end of the spectru...
The study objective is to analyze incidence of cancer morbidity and morality in Russia and some form...
Introduction The current study determined the level and trends associated with the incidence, death ...
The work is devoted to the dynamics of morbidity and prevalence of chronic cystitis among the male p...
The study uses data from state and industry official statistics for 2008-2017. Absolute and relative...
Introduction: Bladder cancer is the ninth common cancer in the world, the third common cancer among ...
The study uses data from state and industry official statistics for 2008-2017. Absolute and relative...
Bladder cancer accounts for approximately 5-10% of all cancers in the United States and Europe and i...